Rilmakalim

CAS No. 132014-21-2

Rilmakalim( —— )

Catalog No. M34129 CAS No. 132014-21-2

Rilmakalim is a potassium channel opener. Rilmakalim shows antivasoconstrictor effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 304 In Stock
10MG 456 In Stock
25MG 747 In Stock
50MG 1004 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rilmakalim
  • Note
    Research use only, not for human use.
  • Brief Description
    Rilmakalim is a potassium channel opener. Rilmakalim shows antivasoconstrictor effect.
  • Description
    Rilmakalim (HOE 234) is a potassium channel opener(PCO) that activates ATP-sensitive K+ channels in theheart or other tissues.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132014-21-2
  • Formula Weight
    401.48
  • Molecular Formula
    C21H23NO5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@@H](C=2C(=CC=C(S(=O)(=O)C3=CC=CC=C3)C2)OC1(C)C)N4C(=O)CCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kocic, Ivanet al. Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, toactivate ATP-sensitive K(+) current in guinea pig ventricular myocytes. Journalof pharmacological sciences vol. 95,2 (2004): 189-95.?
molnova catalog
related products
  • Phrixotoxin 3

    Potent blocker of voltage-gated sodium channels (IC50 values are 0.6, 42, and 72 nM for NaV1.2, NaV1.3 and NaV1.5 respectively). Blocks inward sodium currents in a voltage-dependent manner.

  • Flecainide

    A class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias, works by blocking the Nav1.5 sodium channel in the heart.

  • ProTx II

    Selective NaV1.7 channel blocker. Shifts activation gating positively and decreases current magnitude. Displays 100-fold selectivity over other sodium channel subtypes.